Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Celyad Oncology SA Celyad Oncology announces intention to terminate SEC reporting obligations February 08, 2024 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook January 16, 2024 From Celyad Oncology SA Via GlobeNewswire Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007) December 20, 2023 From Celyad Oncology SA Via GlobeNewswire Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) December 15, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad announces management change December 04, 2023 From Celyad Oncology SA Via GlobeNewswire Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007) December 01, 2023 From Celyad Oncology SA Via GlobeNewswire Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007) November 21, 2023 From Celyad Oncology SA Via GlobeNewswire Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) November 14, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology reports third quarter 2023 financial results and recent business highlights November 09, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology announces the termination of its American Depository Receipt program September 25, 2023 From Celyad Oncology SA Via GlobeNewswire Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007) September 15, 2023 From Celyad Oncology SA Via GlobeNewswire Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007) September 12, 2023 From Celyad Oncology SA Via GlobeNewswire Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007) September 07, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) September 05, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights September 04, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders August 24, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology announces receipt of Nasdaq delisting notice May 15, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq May 05, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology reports first quarter 2023 financial results and recent business highlights May 05, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price April 24, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology announces receipt of Nasdaq notice April 04, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology appoints Georges Rawadi as its new CEO March 24, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology reports full year 2022 financial results and recent business highlights March 23, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology to announce full year 2022 financial results and host conference call March 17, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology announces non-cash impairment March 15, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD REPEAT -- Celyad Oncology SA - Letter to Shareholders March 01, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology SA - Letter to Shareholders February 28, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01 February 09, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook February 03, 2023 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property December 21, 2022 From Celyad Oncology SA Via GlobeNewswire Tickers CYAD Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.